Pfizer Inc. · PFE · Next earnings
Pfizer Inc. reports Tuesday, Nov 3, 2026
PFE reports before market open with consensus EPS at $0.79 and revenue at $15.93B. Last quarter: Pfizer Q1 2026: Revenue and EPS Beat, Guidance Reaffirmed, Pipeline Advances
What the street expects
Consensus for the coming reportWhere PFE left off: FY2026 Q1
Full reportPfizer Q1 2026: Revenue and EPS Beat, Guidance Reaffirmed, Pipeline Advances
2026 guidance was reaffirmed at $59.5–62.5B revenue and $2.80–3.00 adjusted EPS, unchanged from the prior quarter's outlook. Management tone remained confident. The dividend was maintained. No changes to the capital allocation framework were announced.
What to watch on the call
Carried forward from the last transcriptAsk FN2 about PFE next report
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Get the PFE recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Recent PFE quarters
All PFE earningsSources
- FN2 corporate events calendar, resolved from the earnings calendar feed
- FN2 earnings calendar analyst consensus
- Earnings call transcript analysis, FY2026 Q1
Methodology
The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.
Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.